Trademarkia Logo

Canada

C$
Trademark Search in Canada
GLX

View On IC.GC.CA

GLX
SEARCHED

on 27 Jan 2025

Last Applicant/ Owned by

GLX Analytix ApS

Ole Maaløes Vej 3DK-2200 København N

DK

Serial Number

2289276 filed on 21st Sept 2023

GLX

Trademark usage description

injectable pharmaceuticals; injectable pharmaceuticals for treatment of anaphylactic reactions; diagnostic reagents for medical use; biological reagen Read More

Classification Information

Class [005]
Injectable pharmaceuticals; injectable pharmaceuticals for treatment of anaphylactic reactions; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes [for medical purposes]; reagents for microbiological analysis [for veterinary purposes]; antibodies; colostral antibodies for medical purposes; pharmaceutical drugs; anti-cancer drugs; drugs for medical purposes; pharmaceuticals; pharmaceuticals and natural remedies; pharmaceutical preparations for the prevention of autoimmune disorders; reagents for blood grouping [for medical purposes]; human immune globulin; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Classification kind code

12

Class [009]
Software; computer software relating to the medical field; software as a medical device [SaMD], downloadable; computer software for use in medical decision support systems; virtual reality software for medical teaching; software for monitoring, analysing, controlling and running physical world operations; health monitoring software; artificial intelligence software for healthcare; machine learning software for healthcare; system and system support software, and firmware; artificial intelligence and machine learning software; artificial intelligence software; artificial intelligence software for analysis; software for the integration of artificial intelligence and machine learning in the field of big data; software for remote diagnostics; software for diagnostics and troubleshooting; downloadable computer software for remote monitoring and analysis; testing software; risk detection software; machine learning software; machine learning software for analysis.

Classification kind code

12

Class [042]
Information technology services for the pharmaceutical and healthcare industries; medical and pharmacological research services; software development, programming and implementation; platforms for artificial intelligence as software as a service [SaaS]; DNA sequencing technology research; DNA testing services to determine paternity (laboratory services); blood analysis services; development and testing of software; software as a service [SaaS] featuring software for machine learning; software as a service [SaaS] services featuring software for machine learning, deep learning and deep neural networks.

Classification kind code

12

Class [045]
Health and safety risk management; health and safety risk assessment services; licensing of intellectual property; licensing industrial property rights; legal services; intellectual property services; licensing of intellectual property in the field of copyrights [legal services]; licensing of intellectual property in the field of trademarks [legal services].

Classification kind code

12

Mark Details

Serial Number

2289276

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 27th Jan 2025		Search Recorded
Submitted for opposition 20
on 27th Jan 2025		Examiner's First Report
Submitted for opposition 223
on 27th Jan 2025		Total Provisional Refusal
Submitted for opposition 256
on 26th Aug 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 26th Oct 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 25th Oct 2023		Formalized
Submitted for opposition 1
on 25th Oct 2023		Created
Submitted for opposition 228
on 21st Sept 2023		International Registration
Submitted for opposition 30
on 21st Sept 2023		Filed